Premium
Cerebrospinal fluid markers of extracellular matrix remodelling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy
Author(s) -
Fernström E.,
Minta K.,
Andreasson U.,
Sandelius Å.,
Wasling P.,
Brinkmalm A.,
Höglund K.,
Blennow K.,
Nyman J.,
Zetterberg H.,
Kalm M.
Publication year - 2018
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.12763
Subject(s) - medicine , cerebrospinal fluid , radiation therapy , conventional pci , neuroinflammation , extracellular matrix , pathology , disease , biology , microbiology and biotechnology , myocardial infarction
Background Advances in the treatment of brain tumours have increased the number of long‐term survivors, but at the cost of side effects following cranial radiotherapy ranging from neurocognitive deficits to outright tissue necrosis. At present, there are no tools reflecting the molecular mechanisms underlying such side effects, and thus no means to evaluate interventional effects after cranial radiotherapy. Therefore, fluid biomarkers are of great clinical interest. Objective Cerebrospinal fluid ( CSF ) levels of proteins involved in inflammatory signalling, synaptic plasticity and extracellular matrix ( ECM ) integrity were investigated following radiotherapy to the brain. Methods Patients with small‐cell lung cancer ( SCLC ) eligible for prophylactic cranial irradiation ( PCI ) were asked to participate in the study. PCI was prescribed either as 2 Gy/fraction to a total dose of 30 Gy (limited disease) or 4 Gy/fraction to 20 Gy (extensive disease). CSF was collected by lumbar puncture at baseline, 3 months and 1 year following PCI . Protein concentrations were measured using immunobased assays or mass spectrometry. Results The inflammatory markers IL ‐15, IL ‐16 and MCP ‐1/ CCL 2 were elevated in CSF 3 months following PCI compared to baseline. The plasticity marker GAP ‐43 was elevated 3 months following PCI , and the same trend was seen for SNAP ‐25, but not for SYT 1. The investigated ECM proteins, brevican and neurocan, showed a decline following PCI . There was a strong correlation between the progressive decline of soluble APP α and brevican levels. Conclusion To our knowledge, this is the first time ECM ‐related proteins have been shown to be affected by cranial radiotherapy in patients with cancer. These findings may help us to get a better understanding of the mechanisms behind side effects following radiotherapy.